SN
GSK icon

Sittner & Nelson’s GSK GSK Stock Holding History

Sittner & Nelson’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$424K Buy
8,088
+35
+0.4% +$1.85K 0.13% 120
2026
Q1 		$444K Hold
8,053
– – 0.16% 103
2025
Q4 		$485K Hold
8,053
– – 0.17% 93
2025
Q3 		$348K Sell
8,053
-100
-1% -$3.91K 0.13% 109
2025
Q2 		$313K Hold
8,153
– – 0.13% 114
2025
Q1 		$316K Buy
8,153
+3,000
+58% +$110K 0.13% 105
2024
Q4 		$174K Sell
5,153
-5,200
-50% -$187K 0.08% 140
2024
Q3 		$423K Buy
10,353
+3,000
+41% +$123K 0.19% 78
2024
Q2 		$283K Hold
7,353
– – 0.14% 90
2024
Q1 		$315K Sell
7,353
-750
-9% -$30.9K 0.16% 91
2023
Q4 		$300K Buy
8,103
+2,684
+50% +$96.4K 0.16% 87
2023
Q3 		$196K Hold
5,419
– – 0.11% 106
2023
Q2 		$193K Sell
5,419
-6,787
-56% -$243K 0.11% 110
2023
Q1 		$434K Buy
12,206
+415
+4% +$14.5K 0.25% 68
2022
Q4 		$414K Buy
11,791
+260
+2% +$8.66K 0.25% 73
2022
Q3 		$339K Buy
11,531
+5,037
+78% +$191K 0.23% 75
2022
Q2 		$353K Sell
6,494
-600
-8% -$33.1K 0.23% 78
2022
Q1 		$386K Buy
7,094
+39
+0.6% +$2.12K 0.22% 75
2021
Q4 		$389K Sell
7,055
-31
-0.4% -$1.61K 0.23% 72
2021
Q3 		$338K Buy
7,086
+1,200
+20% +$60.3K 0.22% 73
2021
Q2 		$293K Hold
5,886
– – 0.21% 70
2021
Q1 		$263K Buy
5,886
+100
+2% +$4.54K 0.2% 74
2020
Q4 		$266K Buy
+5,786
New +$266K 0.24% 72

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Sittner & Nelson's GSK Position: Q2 2026 in Review

Sittner & Nelson increased its GSK (GSK) stake by 0.43% in Q2 2026, buying an estimated $1.85K and bringing the position to 8,088 shares worth $424K. The position accounts for 0.13% of the portfolio, ranked #120.

Sittner & Nelson first reported a position in GSK in Q4 2020 and has held it in 23 quarters since. The position peaked at $485K in Q4 2025. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Sittner & Nelson held 8,088 shares of GSK worth $424K as of Q2 2026.
  • Sittner & Nelson bought 35 GSK shares in Q2 2026, an estimated $1.85K.
  • GSK made up 0.13% of Sittner & Nelson's portfolio in Q2 2026, its #120 holding.
  • Sittner & Nelson first reported a position in GSK in Q4 2020 and has held it in 23 quarters since.
  • Sittner & Nelson's GSK position peaked at $485K in Q4 2025.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Sittner & Nelson's 13F filing for Q2 2026, filed 7 Aug 2026.